What is Sarepta Therapeutics' stock symbol?
Sarepta Therapeutics trades on the NASDAQ under the ticker symbol "SRPT."
Where is Sarepta Therapeutics' stock going? Where will Sarepta Therapeutics' stock price be in 2017?
19 brokerages have issued 1-year price targets for Sarepta Therapeutics' stock. Their predictions range from $5.00 to $106.00. On average, they expect Sarepta Therapeutics' share price to reach $62.15 in the next year.
When will Sarepta Therapeutics announce their earnings?
Sarepta Therapeutics is scheduled to release their next quarterly earnings announcement on Thursday, February, 23rd 2017.
Who owns Sarepta Therapeutics stock?
Sarepta Therapeutics' stock is owned by many different of institutional and retail investors. Top institutional shareholders include State Street Corp (4.83%), FMR LLC (2.19%), Two Sigma Investments LP (0.48%), Fred Alger Management Inc. (0.23%), Guggenheim Capital LLC (0.16%) and Highland Capital Management LP (0.16%). Company insiders that own Sarepta Therapeutics stock include David T Howton, Edward M Md Kaye, Jayant Aphale, M Kathleen Behrens and Sandesh Mahatme.
Who sold Sarepta Therapeutics stock? Who is selling Sarepta Therapeutics stock?
Sarepta Therapeutics' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, State Street Corp, Guggenheim Capital LLC, State Board of Administration of Florida Retirement System, National Planning Corp and United Capital Financial Advisers LLC. Company insiders that have sold Sarepta Therapeutics stock in the last year include David T Howton, Edward M Md Kaye, Jayant Aphale and Sandesh Mahatme.
Who bought Sarepta Therapeutics stock? Who is buying Sarepta Therapeutics stock?
Sarepta Therapeutics' stock was purchased by a variety of institutional investors in the last quarter, including Two Sigma Investments LP, Highland Capital Management LP, Allianz Asset Management AG, Renaissance Technologies LLC, AQR Capital Management LLC, Russell Investments Group Ltd., Fred Alger Management Inc. and Raymond James Financial Services Advisors Inc..
How do I buy Sarepta Therapeutics stock?
Shares of Sarepta Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Sarepta Therapeutics stock cost?
One share of Sarepta Therapeutics stock can currently be purchased for approximately $28.28.